At the time of writing, Omega Therapeutics Inc [OMGA] stock is trading at $1.04, up 14.96%. An important factor to consider is whether the stock is rising or falling in short-term value. The OMGA shares have gain 5.23% over the last week, with a monthly amount drifted -27.27%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Omega Therapeutics Inc [NASDAQ: OMGA] stock has seen the most recent analyst activity on June 18, 2024, when Raymond James initiated its Outperform rating and assigned the stock a price target of $12. On December 08, 2022, H.C. Wainwright initiated with a Buy rating and assigned a price target of $11 on the stock. Chardan Capital Markets started tracking the stock assigning a Buy rating and suggested a price target of $12 on September 23, 2022.
For the past year, the stock price of Omega Therapeutics Inc fluctuated between $0.89 and $6.30. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. Omega Therapeutics Inc [NASDAQ: OMGA] shares were valued at $1.04 at the most recent close of the market. An investor can expect a potential return of 765.38% based on the average OMGA price forecast.
Analyzing the OMGA fundamentals
According to Omega Therapeutics Inc [NASDAQ:OMGA], the company’s sales were 6.31M for trailing twelve months, which represents an 181.16% jump. Gross Profit Margin for this corporation currently stands at 0.04% with Operating Profit Margin at -12.77%, Pretax Profit Margin comes in at -12.5%, and Net Profit Margin reading is -12.5%. To continue investigating profitability, this company’s Return on Assets is posted at -0.47, Equity is -1.56 and Total Capital is -0.57. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.9333 points at the first support level, and at 0.8267 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.1033, and for the 2nd resistance point, it is at 1.1667.
Ratios To Look Out For
It is important to note that Omega Therapeutics Inc [NASDAQ:OMGA] has a current ratio of 2.19. On the other hand, the Quick Ratio is 2.19, and the Cash Ratio is 1.81. Considering the valuation of this stock, the price to sales ratio is 9.09, the price to book ratio is 2.18.
